An expanded access program evaluating cretostimogene grenadenorepvec was highlighted during the 25th Annual Meeting of the ...
Updates on ILYX-002 will be the focus of the upcoming Iolyx presentations, for which further details can be found below. Presenter: Erin Newman, Chief Development Officer at Iolyx Presenter: Dr. Mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback